Galmed Pharmaceuticals Ltd. (GLMD)
Market Closed
9 Sep, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
4. 63
+0.8
+21.0458%
Pre Market
$
-1.01 -21.8143% 3. 62
4.78M Market Cap
- P/E Ratio
- Div Yield
301,155 Volume
-1.29 Eps
$ 3.83
Previous Close Investors:
Want to track GLMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Galmed Pharmaceuticals Ltd. (GLMD) Statistics
Valuation metrics
Market Cap 4.78M
Enterprise value 1.87M
Trailing P/E (ttm) -0.34
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.35
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.7K
Average volume (90 days) 1.23M
Price summary
52-Week low 3.29
52-Week high 13.2
Beta -
50-Day moving average 3.72
200-Day moving average 1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 19 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.62%
Return on equity -0.74%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -11.91
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.96
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.16%
Book value per share (mrq) 13.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
